Last reviewed · How we verify

LTOT 15h/day — Competitive Intelligence Brief

LTOT 15h/day (LTOT 15h/day) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Respiratory/Pulmonology.

marketed Respiratory/Pulmonology Small molecule Live · refreshed every 30 min

Target snapshot

LTOT 15h/day (LTOT 15h/day) — Skane University Hospital. LTOT 15h/day refers to long-term oxygen therapy administered for 15 hours per day, which increases blood oxygen saturation in patients with chronic hypoxemia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LTOT 15h/day TARGET LTOT 15h/day Skane University Hospital marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LTOT 15h/day — Competitive Intelligence Brief. https://druglandscape.com/ci/ltot-15h-day. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: